Skip to content

ED Hypernatremia. Prognostic Factors and Epidemiology.

Emergency Departement (ED) Hypernatremia. Prognostic Factors and Epidemiology. About a Single-center Prospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04265976
Acronym
NATSAU
Enrollment
250
Registered
2020-02-12
Start date
2019-08-26
Completion date
2020-09-01
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypernatremia

Brief summary

This study evaluate the 1-month mortality of patients who proceed a blood sample while in the ED with an hypernatremia (\>145 mmol/l). This prospective study will try to show several prognostic factors, and show the epidemiology of hypernatremia in this single center evaluation.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Natremia \> 145 mmol/l

Exclusion criteria

* Age \< 18 years * Refusal

Design outcomes

Primary

MeasureTime frameDescription
one month survival1 monthSurvival at 1 month after the blood sample at the ED

Countries

France

Contacts

Primary ContactRomain ADAM, Resident
radam@chu-besancon.fr+33646470168

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026